The Tyrosine Kinase Src Regulates Adhesion and Survival in Waldenstrom Macroglobulinemia.

被引：0

作者：

Ngo, Hai T. ^{[1
]}

Farag, Mena ^{[1
]}

Jia, Xiaoying ^{[1
]}

Burwick, Nicolas ^{[1
]}

Methem, Molly R. ^{[1
]}

Leleu, Xavier ^{[2
]}

Runnels, Judith ^{[1
]}

Azab, Abdel Kareern ^{[1
]}

Roccaro, Aldo M. ^{[1
]}

Azab, Feda ^{[1
]}

Sacco, Antonio ^{[1
]}

Quang, Phong ^{[1
]}

Tai, Yu-Tzu ^{[1
]}

Anderson, Kenneth C. ^{[1
]}

Ghobrial, Irene M. ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Ctr Hosp Reg & Univ Lille, Hop Huriez, Serv Malad Sang, F-59037 Lille, France

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：906 / 906

页数：1

共 50 条

[31] The tyrosine kinase Src regulates adhesion to the substrate of pancreatic endocrine cancer cells
Di Florio, Alessia
Capurso, Gabriele
Milione, Massimo
Panzuto, Francesco
Geremia, Raffaele
Sette, Claudio
Delle Fave, Gianfranco
GASTROENTEROLOGY, 2006, 130 (04) : A582 - A582
[32] Tyrosine kinase Src regulates adhesion to the substrate of pancreatic endocrine cancer cells
Di Florio, A
Capurso, G
Milione, M
Panzuto, F
Geremia, R
Sette, C
Delle Fave, G
NEUROENDOCRINOLOGY, 2006, 83 (01) : 56 - 56
[33] Abnormal expression of TRAF adapter, proteins in waldenstrom's macroglobulinemia.
Leleu, Xavier
Xu, Lian
Hunter, Zachary R.
Moreau, Anne-Sophie
Jia, Xiaoying
O'Sullivan, Garrett
Bakthavachalam, Vinod
Ho, Allen W.
Hatjiharissi, Evdoxia
N'Go, Hai T.
Santos, Daniel D.
O'Connor, Kelly
Manning, Robert
Soumerai, Jacob
Patterson, Christopher
Ghobrial, Irene M.
Treon, Steven P.
BLOOD, 2006, 108 (11) : 241B - 241B
[34] Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemia
Roccaro, Aldo M.
Leleu, Xavier
Sacco, Antonio
Jia, Xiaoying
Melhem, Molly
Moreau, Anne-Sophie
Ngo, Hai T.
Runnels, Judith
Azab, Abdelkareem
Azab, Feda
Burwick, Nicholas
Farag, Mena
Treon, Steven P.
Palladino, Michael A.
Hideshima, Teru
Chauhan, Dharminder
Anderson, Kenneth C.
Ghobrial, Irene M.
BLOOD, 2008, 111 (09) : 4752 - 4763
[35] Phenotypic and clinical evidence supports rituximab for Waldenstrom's macroglobulinemia.
Weber, DM
Gavino, M
Huh, Y
Cabanillas, F
Alexanian, R
BLOOD, 1999, 94 (10) : 125A - 125A
[36] Activity of alemtuzumab (Mabcampath) in relapsed/refractory Waldenstrom's macroglobulinemia.
Owen, RG
Rawstron, AC
Osterborg, A
Lundin, J
Svensson, G
Hillmen, P
BLOOD, 2003, 102 (11) : 644A - 645A
[37] Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenstrom Macroglobulinemia
Kuiatse, Isere
Baladandayuthapani, Veerabhadran
Lin, Heather Y.
Thomas, Sheeba K.
Bjorklund, Chad C.
Weber, Donna M.
Wang, Michael
Shah, Jatin J.
Zhang, Xing-Ding
Jones, Richard J.
Ansell, Stephen M.
Yang, Guang
Treon, Steven P.
Orlowski, Robert Z.
CLINICAL CANCER RESEARCH, 2015, 21 (11) : 2538 - 2545
[38] Bruton tyrosine-kinase inhibitor on the rise: acalabrutinib in Waldenstrom macroglobulinemia
Buske, Christian
LANCET HAEMATOLOGY, 2020, 7 (02): : E85 - E86
[39] The PI3K/Akt pathway is an important regulator of homing and adhesion in waldenstrom's macroglobulinemia.
Leleu, Xavier
Ngo, Hai
Runnels, Judy
Pitsillides, Costas
Spencer, Joel
Moreau, Anne-Sophie
Hatjiharisi, Evdoxia
Jia, Xiaoying
O'Sullivan, Garrett
Treon, Steven
Hideshima, Teru
Lin, Charles
Anderson, Kenneth
Ghobrial, Irene
BLOOD, 2006, 108 (11) : 684A - 684A
[40] A Phase II Trial of Ofatumumab In Subjects with Waldenstrom's Macroglobulinemia.
Furman, Richard R.
Eradat, Herbert
Switzky, Julie C.
Hayman, Suzanne R.
Hofmeister, Craig C.
Avignon, Nathalie A.
Leonard, John P.
Coleman, Morton
Liao, Qiming
Shah, Damini N.
Brownell-Buttich, Stephanie
Lisby, Steen
Lin, Thomas S.
BLOOD, 2010, 116 (21) : 749 - 750

← 1 2 3 4 5 →